Condition: Aortic Valve Stenosis · Sponsor: Meril Life Sciences Pvt. Ltd.
The primary objective of this study (LANDMARK) is to compare the safety and effectiveness of the Myval THV Series with Contemporary Valves (Sapien THV Series and Evolut THV Series) in patients with severe symptomatic native aortic valve stenosis. This study will be done in total 768 subjects (384:384, Myval THV Series vs. Contemporary Valves) The randomisation will be carried out with an allocation ratio of 1:1 between Myval THV Series vs. Contemporary Valves (Sapien THV Series and Evolut THV Series)
This description comes directly from the study's public registry record.
Ashok Thakkar, PhD · +91-9879443584 · ashok.thakkar@merillife.com
Always discuss trial participation with your own doctor first.
| Republican Scientific-Practical Centre "Cardiology" | Minsk, Belarus | Not Yet Recruiting |
| Hospital Dante Pazanesse | São Paulo, Brazil | Recruiting |
| Split Clinical Hospital Center | Split, Croatia | Recruiting |
| University Hospital Dubrava Avenija Gojka Šuška 6 | Zagreb, Croatia | Recruiting |
| North Estonia Medical Center | Tallinn, Estonia | Recruiting |
| Hôpital Henri Mondor | Créteil, France | Recruiting |
| Lille University | Lille, France | Recruiting |
| Institut Cardiovascular Paris-Sud | Massy, France | Recruiting |
| Arnault Tzanck Institute | Nice, France | Recruiting |
| Centre Hospitalier Universitaire De Rennes | Rennes, France | Not Yet Recruiting |
| Kerckhoff-KlinikForschungs GmbH | Bad Nauheim, Hesse, Germany | Recruiting |
| Leipzig Heart Institute GmbH | Leipzig, Saxony, Germany | Recruiting |
+ 42 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04275726